Ethos Life

Ethos Life (legal entity: Ethos Technologies, Inc.) is a San Francisco–based AI-native digital life insurance platform founded in 2016 by Peter Colis and Lingke Wang. It digitizes the US life insurance value chain — marketing, application intake, no-exam underwriting, policy activation, payments, and administration — so consumers receive binding decisions in minutes rather than the 6–8 weeks required by traditional paramedical-exam workflows.

Business footprint. Ethos raised ~$400 million across Series A–D: Sequoia led Series A in 2018; Accel led the $35M Series B later that year with GV, Roc Nation's Arrive (Jay-Z), Stanford, and celebrity LPs (Robert Downey Jr., Kevin Durant, Will Smith); Goldman Sachs joined the $60M Series C in 2019; General Catalyst led the $200M Series D in May 2021 at a $2B valuation; SoftBank Vision Fund 2 added $100M in July 2021 at $2.7B. On January 29, 2026, Ethos priced its IPO at $19.00/share on Nasdaq under ticker LIFE, raising $200M. Shares closed day one at $16.85, giving a ~$1.1B market cap — a material markdown from the 2021 peak. Per the S-1/424B4, Ethos reported $344.06M revenue and $56.14M net income for the twelve months ended September 30, 2025, and has been profitable since mid-2023 with >50% YoY revenue growth.

MGA-as-tech structure. Ethos does not take insurance risk. It operates a three-sided platform connecting consumers, independent agents, and carrier partners, and earns commissions on activated policies. Capacity sits with Legal & General America (Banner Life), Ameritas, TruStage Financial Group (CMFG Life), and — as of January 2026 — Sammons Financial's North American Company for Life and Health Insurance for an indexed universal life product. This is the defining structural caveat: the underwriting engine belongs to Ethos; the balance sheet does not.

Core product: automated no-exam underwriting. Ethos's underwriting platform ingests ~300,000 data points and applies ~30,000 algorithmic rules in real time — pharmacy benefit manager records, MIB (Medical Information Bureau) files, electronic health records where consented, driving records, and third-party behavioral data — to price and bind most applicants without a medical exam. Product lines span Term Life (core SKU, $20K–$2M face amounts), Whole Life, and Indexed Universal Life, plus ancillary wills and estate-planning tools.

What it replaces. Ethos targets two incumbent workflows: (1) the legacy paramedical-exam underwriting path owned by traditional carriers (Northwestern Mutual, New York Life, MassMutual direct channels), and (2) the agent-led paper application intake process. Carrier partners outsource front-end acquisition, digital UX, and algorithmic triage to Ethos while retaining the reserve-bearing policy.

Category context. The digital no-exam life category has been a bloodbath. MassMutual wound down Haven Life in 2023–2024 citing "lack of consumer adoption" and unsustainable CAC; Haven Technologies (the SaaS sibling) cut ~70% of staff. Ladder — the other Sequoia/Thomvest-backed D2C life pure-play — raised a $100M Series D in October 2021 and has not disclosed comparable profitability or scale. (Note: Zinnia's April 2024 acquisition of Ebix's North American life and annuity assets for ~$400M consolidated back-office life admin, not Ladder itself — Ladder remains independent.) Policygenius was acquired by Zinnia in 2023; Health IQ filed for bankruptcy the same year. Ethos's 2026 Nasdaq listing is the first successful public exit in US digital life insurance.

Gaps. Ethos is absent from publicly indexed Gartner, Forrester, and Celent life underwriting leader quadrants in 2024–2025. Loss-ratio performance of the algorithmic underwriting engine stays inside carrier-partner books and is not independently validated. The $1.1B post-IPO market cap — a ~60% haircut versus the private peak — compresses equity-funded growth optionality and raises the bar for operating leverage.